CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,719,562
- in 13 filings, $45.5M under 10b5-1 plans
Net −$85,719,562. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | MANCHESTER KEITH S Director | Sale | −225,000 | $26.50 | $6.0M | 15,127,329 |
| 2026-02-13 | Gold Daniel Allen Director | Sale | −150,784 | $26.49 | $4.0M | 15,352,329 |
| 2026-02-13 | Gold Daniel Allen Director | Sale | −225,000 | $26.50 | $6.0M | 15,127,329 |
| 2026-02-13 | QVT Financial LP Director by Deputization | Sale | −150,784 | $26.49 | $4.0M | 15,352,329 |
| 2026-02-13 | QVT Financial LP Director by Deputization | Sale | −225,000 | $26.50 | $6.0M | 15,127,329 |
| 2026-02-12 | MANCHESTER KEITH S Director | Sale | −150,000 | $26.72 | $4.0M | 15,778,113 |
| 2026-02-12 | MANCHESTER KEITH S Director | Sale | −275,000 | $26.76 | $7.4M | 15,503,113 |
| 2026-02-12 | Gold Daniel Allen Director | Sale | −150,000 | $26.72 | $4.0M | 15,778,113 |
| 2026-02-12 | Gold Daniel Allen Director | Sale | −275,000 | $26.76 | $7.4M | 15,503,113 |
| 2026-02-12 | QVT Financial LP Director by Deputization | Sale | −150,000 | $26.72 | $4.0M | 15,778,113 |
| 2026-02-12 | QVT Financial LP Director by Deputization | Sale | −275,000 | $26.76 | $7.4M | 15,503,113 |
| 2026-02-11 | MANCHESTER KEITH S Director | Sale | −425,000 | $26.67 | $11.3M | 15,928,113 |
| 2026-02-11 | Gold Daniel Allen Director | Sale | −425,000 | $26.67 | $11.3M | 15,928,113 |
| 2026-02-11 | QVT Financial LP Director by Deputization | Sale | −425,000 | $26.67 | $11.3M | 15,928,113 |
| 2026-02-09 | Sukhatme Mayukh President & CIO | Option exercise | +651,558 | $12.68 | $8.3M | 19,488,105 |
| 2026-02-09 | Sukhatme Mayukh President & CIO | Sale | −339,441 | $26.47 | $9.0M | 19,148,664 |
| 2026-02-09 | Sukhatme Mayukh President & CIO | Other disposition | −312,117 | $26.47 | $8.3M | 18,836,547 |
| 2026-02-09 | Sukhatme Mayukh President & CIO | Option exercise · Stock Option (Right to Buy) | −651,558 | 0 | ||
| 2026-01-20 | MOMTAZEE JAMES C Director | Grant or award | +609 | 109,152 | ||
| 2026-01-20 | MOMTAZEE JAMES C Director | Shares withheld for taxes | −122 | $22.98 | $3K | 109,030 |
Page 11 of 29 · 570 trades